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 Abstract 
Objective: We aimed to estimate the proportion of post-migration HIV acquisition among HIV-
positive migrants in Europe. 
Design:  To reach HIV positive migrants we designed a cross sectional study performed in HIV 
clinics. 
Methods: The study was conducted from July 2013-July 2015 in 57 clinics (9 European 
countries, targeting individuals over 18 years diagnosed in the preceding 5 years and born abroad. 
Electronic questionnaires supplemented with clinical data were completed in any of 15 languages. 
Post-migration HIV acquisition was estimated through Bayesian approaches combining extensive 
information on migration and patients’ characteristics. CD4 counts and HIV-RNA trajectories 
from seroconversion were estimated by bivariate linear mixed models fitted to natural history 
data. Post-migration acquisition risk factors were investigated with weighted logistic regression. 
Results: Of 2009 participants, 46% were men who have sex with men (MSM) and a third 
originated from Sub-Saharan Africa (SSA) and Latin America & Caribbean (LAC), respectively. 
Median time in host countries was 8 years. Post-migration HIV acquisition was 63% (95% CI: 
57%-67%); 72% among MSM, 58% and 51% in heterosexual men and women, respectively. 
Post-migration HIV acquisition was 71% for LAC migrants and 45% for people from SSA. 
Factors associated with post-migration HIV acquisition among heterosexual women and MSM 
were age at migration, length of stay in host country and HIV diagnosis year and among 
heterosexual men, length of stay in host country, and HIV diagnosis year.  
Conclusions: A substantial proportion of HIV-positive migrants living in Europe acquired HIV 
post-migration. This has important implications for European public health policies.  
Keywords: HIV; Transients and Migrants; Europe 
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Introduction 
Migrants most typically encompass a selected population of healthy young people[1] 
whose drivers are largely labour and education markets. Migration is also fuelled by 
economic and political instability[2]. Despite this, compared with native populations, 
migrants are at increased risk of many diseases, including HIV infection[3, 4]. This is 
attributable to individual behaviours, structural factors and social inequalities[3, 4] which 
increase the vulnerabilities of migrant populations through limited access to HIV 
prevention, testing and care[3, 5]. 
In 2015, 29,747 new HIV diagnoses were reported in the European Union (EU) and the 
European Economic Area (EEA), information on geographical origin was available for 
25,785, and of these, 9,347 (37%) were in people from outside of the reporting country, 
migrants, and 3,768 (15%) from countries with generalized HIV epidemics[6]. Most EU 
countries consider migrants as a priority population in their national response to HIV[7]. 
In the past, most HIV infections in migrants in Europe, particularly among those from 
Sub-Saharan African (SSA), were assumed to have been imported[8, 9]. There is 
mounting evidence that HIV infections in migrants are being increasingly acquired post-
migration[10-15]. This concerns the two populations most affected by HIV in Europe, 
African communities and men who have sex with men (MSM) from different 
geographical regions, but hardly any data are available from migrant MSM [16]. 
Knowing whether HIV acquisition occurs pre or post-migration is critical in designing 
adequate HIV prevention and testing strategies. Obtaining reliable estimates, though, 
requires a combination of behavioural and clinical data, as well as detailed information of 
migratory paths which is hard to implement on routine bases. There is no consensus on 
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how to best determine timing of HIV infection and different methodologies have adopted 
[12-15]. Further, all published studies to date have been confined to one city or one 
country and most have addressed heterosexually transmitted HIV among people from 
SSA[12, 15, 17]. 
In this article we estimate the proportion of post-migration HIV acquisition, and factors 
associated with it, among HIV-positive migrants diagnosed with HIV in the preceding 5 
years from different geographic origins living in any of the nine EU/EEA countries 
participating in the aMASE (Advancing Migrant Access to Health Services in Europe) 
study[18]. 
 
Methods 
Study design, setting and participants 
We designed a multicenter cross-sectional study whose full methodology has been 
described elsewhere[18]. Participants’ were over 18 years old, diagnosed with HIV in the 
preceding five years (to minimize recall bias), living outside their country of birth and 
residing in one of the nine following countries for at least six months: Belgium, 
Germany, Greece, Italy, The Netherlands, Portugal, Spain, Switzerland and the United 
Kingdom. Patients had to consent to participate and be able to complete alone or assisted 
an electronic survey in any of the 15 languages (Amharic, Arabic, Dutch, English, 
French, German, Greek, Italian, Polish, Portuguese, Russian, Turkish, Tigrinya, Spanish, 
Somali). In Switzerland, migrants from neighbouring Austria, France, Germany and Italy 
were excluded. A convenience sample was recruited within 57 HIV clinics (Appendix 1 , 
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http://links.lww.com/QAD/B119) across the EuroCoord European Network of Excellence on HIV 
Research (www.eurocoord.net). Data collection took place July 2013-July 2015. 
 
Sample size calculation  
Sample size calculations were estimated for the proportion of subjects with previous 
HIV-negative tests, as described in the methodology article by the aMASE study 
group[18]. The target sample size was 2000 HIV-positive migrants who were recruited 
from a minimum of two clinics in each country, with each clinic forming a discrete 
cluster.  Within cluster correlation was estimated to be relatively weak (e.g. 0.005)[18]. 
This sample size (n=2000) was sufficient for the question addressed in this manuscript as 
the assumed proportion of post-migration HIV acquisition was 50% with a precision of 
5%-10%. 
 
Variables and definitions  
A questionnaire was designed in collaboration with community partners to gather the 
following information: socio-economic and clinical data; sexual and drug use behaviour; 
migratory trajectories, including dates of arrival into the host country; and residency 
status. Whenever possible, items were adapted from existing survey instruments[18]. The 
survey was delivered using a computer assisted self- or personal-interview (CASI or 
CAPI) using a tablet or PC available on- and offline to minimize interviewer and 
interviewee bias, supplemented with clinical data from patient records within the 
participating clinics. Clinical data included: previous HIV tests, CD4 cell counts, viral 
load determinations, HIV-1 subtypes, clinical events and Antiretroviral Therapy (ART) 
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initiation. For the current analyses, our outcome of interest was the time of HIV-
acquisition (pre or post-migration).  
 
Statistical analyses 
The probability of pre- or post-migration infection was estimated through a Bayesian 
approach that combined information on migration history, risk factors and patients’ 
characteristics including CD4 cell count and HIV-RNA measurements. Full statistical 
methods were presented elsewhere [19] and in the Web appendix (see Text, 
Supplemental Digital Content 1 , http://links.lww.com/QAD/B120). We assumed subjects 
could have not been infected with HIV before: i) the age of ten years (since patients in 
this analysis were not vertically infected); ii) 1/1/1980 and iii) the date of a documented 
HIV negative test. Starting from a uniform prior distribution for the seroconversion date 
over time at risk, we incorporated information from available CD4 cells counts and HIV-
RNA levels measurements before AIDS development and ART initiation. CD4 cell 
counts and HIV-RNA trajectories from HIV seroconversion were estimated by a bivariate 
linear mixed model (LMM) fitted to natural history data from the CASCADE 
collaboration[20]. CASCADE comprises data of over 30.000 HIV-positive persons with 
documented dates of HIV seroconversion from 29 cohorts across Europe, Canada and 
Australia. Demographic covariates such as sex, current age, mode of infection and region 
of birth along with calendar year of seroconversion were incorporated in the model as 
virulence may increase over the epidemic's course[21]. For individuals participating in 
aMASE, we derived the posterior distribution of the time between HIV seroconversion 
and HIV diagnosis applying the Bayes’ rule assuming parameters obtained by the 
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bivariate LMM as known (see Text, Supplemental Digital Content 1, 
http://links.lww.com/QAD/B120). We further extended this method by considering 
absence or presence of AIDS at diagnosis, incorporating the distribution of time to AIDS 
obtained from CASCADE data (censored at 1996 due to the introduction of ART). 
Additionally, behavioral data were also considered by assigning prior probabilities of 
HIV acquisition pre or post-migration based on expert’ opinion (HIV researchers with 
more than 15 years’ experience in HIV epidemiology). Table 1 summarizes the assigned 
pre or post-migration probabilities for sexual and drug use behaviour data. In case of no 
agreement between experts, the figures closest to 0.5 (i.e. the less informative) were 
considered (bold in the Table). Analyses were also done removing these prior 
probabilities. The posterior probabilities of pre or post-migration infection were obtained 
through numerical integration over the posterior distribution of the time between HIV 
seroconversion and diagnosis dates (see Text, Supplemental Digital Content 1). For 
patients who were known to have been infected pre or post-migration (through a 
documented or self-reported HIV positive test pre-migration or a documented HIV 
negative test after migration followed by a positive one, respectively) the aforementioned 
Bayesian method was not applied but they were included in the final analysis assigning to 
them pre or post-migration probability equal to one as appropriate. The combination of 
behavioral, documented seroconversion and inferences from joint CD4 and VL 
modelling, allowed classifying 95% of all HIV infections as pre or post-migration 
acquisitions. To investigate the validity of our approach we applied it to individuals 
known to be infected pre or post-migration (based on their HIV testing history). The 
results of this analysis showed that our method was able to correctly identify post and 
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pre-migration infections (e.g. individuals with an estimated probability of post-migration 
infection >0.5 were classified as infected post-migration), in about 85% of the cases. 
Uncertainty in the estimation of the date of HIV seroconversion (and the resulting 
uncertainty in the classification of HIV acquisition as pre or post-migration) was taken 
into account using a multiple imputations approach. More specifically, after deriving the 
posterior distribution of unknown seroconversion time for each individual, 50 random 
samples were drawn for each participant (using rejection sampling). In each one of the 
resulting datasets (n=50), subjects were classified as being infected pre- or post-migration 
based on the imputed seroconversion time. Results for all subsequent analyses were 
based on the combination of results from the imputed datasets according to Rubin’s rules 
[22]. Potential clinics and/or countries clustering effects were investigated and taken into 
account through multilevel logistic regression models. Initially, three-level logistic 
models (i.e. participants nested within clinics nested within countries) were fitted. 
However, the variance of the countries’ random effects was approximately zero and non-
significant given other significant prognostic factors. Thus, all subsequent analyses were 
based on two-level random effects logistic regression models with clinics as the 
clustering variable. Associated p-values were derived using Wald type tests. 
 
The probabilities of post-migration HIV acquisition, and their 95% Confidence Intervals 
(CI), were estimated by geographical origin, transmission categories and destination 
country. Separate analyses were conducted for HIV transmitted heterosexually in men 
and in women (only reported heterosexual sex and never injected drugs), for MSM 
(MSM who never injected drugs) and for people who inject drugs (PWID). Socio-
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demographic factors associated with post-migration HIV acquisition were investigated 
for each transmission category through multivariable random effects logistic regression as 
described above.  We specified the following a priori variables which could be associated 
with post-migration HIV acquisition: age at arrival to  host country, age at HIV diagnosis, 
geographical origin (Europe, SSA, Latin-America & The Caribbean, other), length of 
stay in host country (< six years, six to ten years, > ten years), residency status (EU/EEA 
nationals/with residency permit, visa/asylum/refugee status, uncertain/unknown status), 
civil status (married/living with couple, single, divorced/separated/widowed), has 
children (yes/no), educational level (primary or less, secondary, university), employment 
status (working, unemployed, not allowed to work due to immigration reasons, student, 
retired/long term disability, family care/voluntary work and unknown), salary (less that 
minimum wage (MW), does not earn his/her own wage, above or similar to MW, rather 
not say). The final model was constructed through a backward stepwise procedure with 
the removal p-value equal to 0.15 whereas area of origin was included irrespective of its 
significance due to its importance in the specific study.  
Statistical analyses were performed by using Stata software (Version 13.1; College 
Station, TX USA) and R (Version 3.4.0; R Foundation for Statistical Computing, Vienna, 
Austria) 
 
Ethics 
Ethical approval for  aMASE  was received separately in each country [18]. 
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Results 
Of 3794 patients registered on enrolment logs, 3251 HIV-positive migrants were invited 
to participate of whom 3152 were eligible and 2209 (70%) accepted and completed the 
survey. Participation was higher in men (74%) than in women (62%), decreased with age 
(83% in people aged 18-24 and 70% in those aged 55-64) and was higher in migrants 
from Latin America (86%) and Eastern Europe (82%) and lower in those from Sub-
Saharan Africa (59%). Out of these 2209, 2117 (96%) had supplementary clinical data. 
Recruitment was as follows: Belgium (256), Germany (31), Greece (175), Italy (64), The 
Netherlands (119), Portugal (182), Spain (710), Switzerland (178) and United Kingdom 
(402). 
Overall, 68%  were men , the proportion of transgender men or women was low (1%, 
n=24). Median age was 36 years (Interquartile Range, IR: 30-44). A third  were from 
SSA and   Latin America & Caribbean, respectively, followed by Western (11%), Central 
(10%) and Eastern (5%). Almost half of participants were MSM (46%). The median time 
in host countries was 8 years (IR: 4-13). Heterosexually transmitted cases were largely 
from SSA (61%), the proportion of women was 65%, educational level was the lowest 
(32% with primary education or less) and 26% did not have permanent resident status. 
MSM were mainly from Latin America and Caribbean (47%) and Europe (35%) and their 
socio-economic profile was more favourable than heterosexually transmitted cases. 
PWID were largely from Europe (50%) and predominantly men (88%) (Table 2). 
Of the 2117 study participants with clinical data, 2009 (95%) had enough information to 
estimate time of HIV acquisition. Of them, 129 (6.4%) and 624 (31.1%) were classified 
as definitely infected pre or post-migration through a documented or self-reported HIV 
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positive test pre-migration or a documented HIV negative test after migration, 
respectively. Taking into account all available data, the overall proportion of post-
migration HIV acquisition was 63% (95% CI: 57%-67%). Post-migration HIV 
acquisition was higher among MSM (72%) and PWID (75%) compared to heterosexual 
men (58%) and women (51%). Post-migration HIV acquisition was higher in migrants 
from Europe (71%) and Latin America & Caribbean (71%) compared to migrants from 
SSA (45%) (Figure 1a). Estimated probabilities of post-migration HIV acquisition in the 
nine participating countries are shown in Figure 1b with Netherlands, Spain and UK 
having the highest ones (72%, 71% and 67%, respectively) and Italy, Belgium and 
Switzerland the lowest estimates (27%, 42% and 46%, respectively). Overall differences 
by country were statistically significant (p<0.001) but became non significant after 
adjustment for transmission category and length of stay (p=0.430). Analyses without 
assigning prior probabilities yielded similar results: the estimated overall probability 
(95% CI) of post-migration infection became 61% (56, 65) instead of 63% (57, 67). 
Similar differences were observed when estimating the same probability by region of 
origin [e.g. European migrants 69% (63, 74) instead of 71% (65, 76), SSA migrants 44% 
(38, 50) instead of 45% (39, 52)]. 
Table 3 shows the percentages of post-migration HIV acquisition (i.e. the proportion of 
individuals with an estimated probability of post-migration infection >0.5) by mode of 
transmission for each  sociodemographic characteristic. In the multivariate regression 
analyses, among heterosexual women and among MSM, the factors associated with the 
probability of acquiring HIV post-migration were length of stay and age at arrival in the 
host country and year of HIV diagnosis (Table 4). For heterosexual men, factors 
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associated with post-migration HIV acquisition were length of stay in the host country 
and the year of HIV diagnosis (Table 4). Additionally, among MSMs, those in 
visa/asylum or refugee status and those with unknown status were less likely to be 
infected post-migration compared to those of EU nationalities or with residence permit. 
Geographical region of origin did not remaine a significant risk factor in the multivariate 
analyses apart from some weak indications for lower probabilities of post-migration HIV 
acquisition in heterosexual men from Sub-Saharan Africa compared to migrants from 
Europe [OR: 0.4 (95% CI: 0.1-1.4; p=0.144.  
Numbers were too low to perform multivariate analyses in PWID. 
Discussion 
Our study suggests that 63% of HIV-positive migrants in aMASE – who were diagnosed 
within the preceding 5 years - acquired HIV after migrating into Europe. The proportion 
of post-migration HIV acquisition varies by patients’ origin which is closely linked to the 
mode of HIV transmission. Latin-America & Caribbean MSM appear to be particularly at 
risk, 79% of all HIV infections in this group were acquired most likely post-migration. 
Among heterosexual migrants from SSA more than 40% of all HIV infections seem to be  
acquired post-migration. Although numbers are considerably lower among PWID, the 
probability of post-migration HIV acquisition exceeded 74% for all geographical origins. 
Length of stay and age at arrival in the host country were associated with post-migration 
HIV acquisition of sexually transmitted HIV; the longer the duration of residence and the 
younger the age at migration, the higher the probability of becoming HIV infected after 
migration. Post-migration HIV acquisition was more common in recent periods for the 
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sexually transmitted cases and only for MSM was commoner for those with secure 
immigration status.  
Migrants included in this study are not representative of migrants living with HIV in the 
9 participating countries, but rather a convenience sample from large HIV testing sites of 
migrants diagnosed with HIV in the preceding 5 years. Indeed, this selection bias needs 
to be taken into account when comparing our findings with other studies. Whereas the 
restriction to HIV diagnoses within preceding 5 years may hamper comparisons with 
other studies, this was a deliberate decision to minimize recall bias given the extensive 
information on migration and risk behaviour history we aimed to collect. 
Our results are consistent with previous publications but provide new information to 
guide public health policy and practice. Fakoya et al.[13] described in a systematic  
review that HIV acquisition after migration could range from 2% in Switzerland among 
people from countries with a generalized epidemic[23] to 62% among migrant black 
Caribbean MSM in the UK[24]. Overall differences between countries were highly 
significant, but after adjustment for differences in the distribution of transmission 
category and length of stay, differences became clearly non-significant.  
Rice et al. estimated that 31% of HIV-positive black Africans reported through national 
surveillance had become infected after arrival to the UK between 2004-2010[15]. 
Desgrees et al. in the PARCOUR study which looked at a representative sample of Sub-
Saharan Africans in the Paris Area from 2012-13 published that from one third to half 
(depending on the assumptions made) of HIV-positive Africans were infected post-
migration[12]. Brannstrom et al. showed that 19% of those diagnosed with HIV-1 
infection in the period 1983−2013 acquired HIV after migrate to Sweden[10]. Migrants 
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can suffer an increased risk of acquiring HIV in destination countries related to the 
socioeconomic and structural inequalities they may have to endure[25, 26]. The 
probability of post-migration HIV acquisition increased overtime for migrant MSM and 
for men and women from SSA and this is consistent with the dynamics of sexually 
transmitted infections and the convergence of health patterns of migrant populations with 
those of native populations from host countries. Similar trends have been observed in 
HIV reports from surveillance data from UK [15] and in a random sample of migrants 
from SSA in France [12].  
Our study shows that post-migration HIV acquisition in Europe in migrant MSM is very 
frequent, irrespective of their geographical origin even if our estimates are not 
population-based. Many MSM migrate to be able to live in less homophobic 
environments[27]; this can  place them at higher risk of HIV as many EU cities have 
higher HIV prevalence among MSM than the reported for MSM in their countries of 
origin[28, 29]. Further, many migrant MSM have to deal with deep-rooted stigma and 
some studies show that migrant MSM are reluctant to disclose their sexual orientation to 
members of their communities[30]. Consequently, many live their sexuality under cover, 
creating challenges for preventive interventions. The process of migration itself can 
influence sexual behaviors with data suggesting disconnection from the traditional 
systems of social control and a greater frequentation of gay venues which results in 
increased sexual activity, particularly in the first phases of migration[27]. Sexual mixing, 
the use of commercial sex and changing perceptions of risk behaviors in origin versus 
destination countries are all contributing factors to high-risk behaviors. Our data are 
concordant with Diez et al. in Spain[16] and Dougan et al. in UK[24] and highlight the 
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need to develop specific health promotion interventions targeting MSM from all migrant 
groups, soon after arrival to Europe, as previously stated by Elford et al.[31]. 
Among heterosexuals in aMASE, post-migration HIV acquisition is less common in 
people from SSA compared to people from other regions. It accounts, nevertheless, for 
more than 40% of all HIV infections and highlights prevention gaps in the migrant group 
with the largest burden of HIV in Europe[15, 19, 21]., Length of stay in the host country,  
age at arrival and  year of HIV diagnosis confounded associations observed in univariate 
analyses and after taking these into account geographical origin was no longer a risk 
factor for post-migration acquisition. Post-migration HIV acquisition among PWID was 
also high irrespective of geographical origin. Similar to previous analyses, the younger 
the age at migration and the longer the duration of stay in the host country, the higher was 
the probability of having become HIV infected after migration. However, contrary to 
sexually transmitted HIV, statistical significance of differences seen in PWID, according 
to the year of HIV diagnosis, could not be determined in a multivariable analysis. 
Our study has a number of limitations to acknowledge. The most important one stems 
from  the lack of a clear sampling frame for the HIV-positive migrant population within 
the nine EU/EEA participating countries leading to a potential selection bias of our 
convenience sample. Because response rates were lower in women and migrants from 
SSA, where the probability of post-migration HIV acquisition is lower, the proportion of 
post-migration HIV acquisition in the study may be overestimated. However, the 
distribution of the HIV-positive migrants participating in aMASE is consistent with the 
epidemiology of new HIV diagnoses in each of the 9 countries thus supporting the 
external validity of our findings.  Among most relevant differences is the larger 
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proportion of migrant MSM in our study due to the nature of the participating clinics; 
migrant and gay friendly sites.  [18]. We collected data only from people followed-up in 
HIV clinics therefore selecting those who have been linked to and retained in care, thus 
excluding those migrants who are not within the health system. Though most of the post-
migration HIV acquisition is likely to have occurred in the host country, we cannot 
exclude that circular migrations or visits to travel countries may account for some of 
these[32].      
To our knowledge, this is the first pan-European study that has estimated the proportion 
of post-migration HIV acquisition among people diagnosed in the preceding 5 years 
across all transmission categories and irrespective of geographical origin.  The high level 
of post-migration HIV acquisition provides strong evidence of inadequate HIV 
prevention for migrants across Europe and helps to further identify which sub-groups are 
more at risk.  Interventions – soon after migration into host countries - need to tackle 
migrants’ vulnerabilities to HIV infection and recognise them as a priority group within 
primary and secondary HIV prevention strategies.  
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Figure 1. Estimated post-migration HIV acquisition probability (95% CI) by a) mode of 
transmission and geographical origin and b) destination country (numbers on top of bars 
denote sample size per country) 
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Table 1. Assigned pre‐ and post‐ migration prior probabilities based on behavioural data as 
evaluated by 5 members of the research team. In bold the prior probabilities applied in data. 
  Condition   Probability of 
pre‐migration 
HIV acquisition 
Probability of 
post‐migration 
HIV acquisition 
1  Has an AIDS diagnosis within 3 
months of HIV diagnosis and 
arrived in the same year of 
diagnosis and has no evidence of 
seroconversion  
70%
80% 
80% 
70% 
80% 
30% 
20% 
20% 
30% 
20% 
2  Has not had sex in the country of 
destination and has never 
injected drugs 
65%
60% 
70% 
85% 
85% 
35% 
40% 
20% 
15% 
15% 
3  Has only injected drugs in 
country of origin 
80%
80% 
80% 
80% 
80% 
20% 
20% 
20% 
20% 
20% 
4  Patient with negative self‐
reported HIV test after year of 
arrival  
20%
20% 
20% 
30% 
20% 
80% 
80% 
80% 
70% 
80% 
5  Has only injected drugs in 
country of destination  
20%
20% 
20% 
25% 
25% 
80% 
80% 
80% 
75% 
75% 
6  Has had unprotected sex only in 
country of destination and has 
never injected drugs 
35%
40% 
30% 
30% 
40% 
65% 
60% 
60% 
70% 
60% 
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Table 2. Socio‐demographic characteristics of the study population (n=2117) 
Sample characteristics HET female (n=643) 
HET male 
(n=344) 
MSM 
(n=967) 
PWID 
(n=98) 
Other
/unknown 
(n=65) 
Geographical area of origin                
European migrants  98 (15%)  58 (17%)  335 (35%)  49 (50%)  7 (11%) 
Sub‐Saharan African  401 (62%)  204 (59%)  59 (6%)  9 (9%)  26 (40%) 
Latin America & Caribbean  119 (19%)  49 (14%)  453 (47%)  17 (17%)  28 (43%) 
Other  25 (4%)  33 (10%)  120 (12%)  23 (23%)  4 (6%) 
Gender                
Female  643 (100%)  ‐  ‐  11 (11%)  4 (6%) 
Male  ‐  344 (100%) 967 (100%)  86 (88%)  38 (58%) 
Transgender Male  ‐  ‐  ‐  1 (1%)  18 (28%) 
Transgender Female  ‐  ‐  ‐  ‐  5 (8%) 
Age at interview                
18‐30 years old  162 (25%)  39 (11%)  304 (31%)  19 (19%)  18 (28%) 
31‐50 years old  401 (62%)  240 (70%)  595 (62%)  70 (71%)  39 (60%) 
51 and more years old  80 (12%)  65 (19%)  68 (7%)  9 (9%)  8 (12%) 
Educational level                
Primary education or less  207 (32%)  110 (32%)  81 (8%)  14 (14%)  23 (35%) 
Secondary education  279 (43%)  145 (42%)  347 (36%)  38 (39%)  33 (51%) 
University degree  157 (24%)  89 (26%)  539 (56%)  46 (47%)  9 (14%) 
Administrative status                
EU nationals/with residence permit  470 (73%)  263 (76%)  855 (88%)  78 (80%)  44 (68%) 
In temporary visa/asylum/refugee 
status  74 (12%)  42 (12%)  44 (5%)  10 (10%)  10 (15%) 
Uncertain status and unknown  99 (15%)  39 (11%)  68 (7%)  10 (10%)  11 (17%) 
Employment                
Working (full and part time)  269 (42%)  170 (49%)  641 (66%)  57 (58%)  35 (54%) 
Unemployed  200 (31%)  120 (35%)  204 (21%)  26 (27%)  16 (25%) 
Other  174 (27%)  54 (16%)  122 (13%)  15 (15%)  14 (22%) 
Salary                
Less than minimum wage (MW)  210 (33%)  99 (29%)  191 (20%)  16 (16%)  21 (32%) 
Do not earn his/her own wage  230 (36%)  115 (33%)  137 (14%)  33 (34%)  14 (22%) 
More/about the same MW  144 (22%)  101 (29%)  576 (60%)  44 (45%)  19 (29%) 
Rather not say  59 (9%)  29 (8%)  63 (7%)  5 (5%)  11 (17%) 
Civil status                
Married or living as a couple  292 (45%)  200 (58%)  367 (38%)  35 (36%)  33 (51%) 
Single  221 (34%)  96 (28%)  513 (53%)  48 (49%)  23 (35%) 
Divorced/separated/widowed  130 (20%)  48 (14%)  87 (9%)  15 (15%)  9 (14%) 
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Has a child/children                
Yes  461 (72%)  253 (74%)  106 (11%)  26 (27%)  26 (40%) 
No  178 (28%)  84 (24%)  854 (88%)  71 (72%)  34 (52%) 
Rather not say  4 (1%)  7 (2%)  7 (1%)  1 (1%)  5 (8%) 
Age at arrival      
Duration of residence in host 
country                
5 years or less  263 (41%)  95 (28%)  312 (32%)  27 (28%)  19 (29%) 
Between 6 and 10 years  175 (27%)  92 (27%)  282 (29%)  34 (35%)  18 (28%) 
More than 10 years  205 (32%)  157 (46%)  373 (39%)  37 (38%)  28 (43%) 
Year of HIV diagnosis                
2008‐2009  95 (15%)  58 (17%)  105 (11%)  16 (16%)  11 (17%) 
2010‐2012  359 (56%)  174 (51%)  464 (48%)  48 (49%)  34 (52%) 
2013‐2015   189 (29%)  112 (33%)  398 (41%)  34 (35%)  20 (31%) 
TOTAL  643 (100%)  344 (100%) 967 (100%)  98 (100%)  65 (100%) 
HET: Heterosexuals; MSM: Men who have sex with men; PWID: People who inject drugs 
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Table 3. Post‐migration HIV acquisition by mode of HIV transmission, sex and socioeconomic 
characteristics [n/N (%); n number of participants with estimated probability of post‐
migration infection > 0.5; N: total number of participants].  
Characteristics  HET female
(N=588) 
HET male
(N=326) 
MSM
(N=938) 
PWID 
(N=94) 
Other/
unknown 
(N=63) 
Area of origin     
European migrants  53/92 (58%) 47/57 (82%) 242/324 (75%) 35/47 (74%)  6/7 (86%)
Sub‐Saharan African  145/360 (40%) 82/188 (44%) 30/58 (52%) 8/9 (89%)  8/24 (33%)
Latin America & Caribbean  75/112 (67%) 31/48 (65%) 349/442 (79%) 12/16 (75%)  20/28 (71%)
Other  11/24 (46%) 22/33 (67%) 82/114 (72%) 20/22 (91%)  4/4 (100%)
Gender     
Female  284/588 (48%) ‐ ‐ 8/10 (80%)  1/4 (25%)
Male  ‐ 182/326 (56%) 703/938 (75%) 67/83 (81%)  21/36 (58%)
Transgender Male  ‐ ‐ ‐ 0/1 (0%)  12/18 (67%)
Transgender Female  ‐ ‐ ‐ ‐  4/5 (80%)
Age     
18‐30 years old  62/146 (42%) 18/37 (49%) 184/293 (63%) 12/19 (63%)  9/18 (50%)
31‐50 years old  175/369 (47%) 120/227 (53%) 460/578 (80%) 56/67 (84%)  23/38 (61%)
51 and more years old  47/73 (64%) 44/62 (71%) 59/67 (88%) 7/8 (88%)  6/7 (86%)
Educational level     
Primary education or less  83/186 (45%) 54/105 (51%) 50/81 (62%) 10/14 (71%)  12/23 (52%)
Secondary education  126/253 (50%) 82/137 (60%) 265/335 (79%) 26/35 (74%)  20/31 (65%)
University degree  75/149 (50%) 46/84 (55%) 388/522 (74%) 39/45 (87%)  6/9 (67%)
Legal status     
EU nationals/with 
residence permit  237/436 (54%) 159/252 (63%) 650/829 (78%) 62/75 (83%)  31/43 (72%)
In visa/asylum/refugee 
status  15/63 (24%)  9/38 (24%)  18/43 (42%)  6/9 (67%)  2/9 (22%) 
Uncertain status and 
unknown  32/89 (36%)  14/36 (39%)  35/66 (53%)  7/10 (70%)  5/11 (45%) 
Employment     
Working  145/253 (57%) 95/165 (58%) 482/624 (77%) 50/56 (89%)  22/35 (63%)
Unemployed  83/177 (47%) 68/110 (62%) 151/196 (77%) 15/24 (63%)  9/16 (56%)
Other  56/158 (35%) 19/51 (37%) 70/118 (59%) 10/14 (71%)  7/12 (58%)
Salary     
Less than MW  99/193 (51%) 53/97 (55%) 125/185 (68%) 10/15 (67%)  13/21 (62%)
Do not earn his/her own 
wage  73/205 (36%)  45/104 (43%)  82/132 (62%)  25/32 (78%)  7/13 (54%) 
More/about the same MW  86/135 (64%) 69/97 (71%) 457/561 (81%) 39/43 (91%)  14/18 (78%)
Rather not say  26/55 (47%) 15/28 (54%) 39/60 (65%) 1/4 (25%)  4/11 (36%)
Civil status     
Married or living with a 
couple  124/267 (46%) 112/191 (59%) 253/358 (71%) 27/34 (79%)  19/32 (59%)
Single  97/200 (49%) 46/90 (51%) 383/495 (77%) 35/46 (76%)  15/23 (65%)
Divorced/separated/widow  63/121 (52%) 24/45 (53%) 67/85 (79%) 13/14 (93%)  4/8 (50%)
Has child      
Yes  207/421 (49%) 139/238 (58%) 78/102 (76%) 18/25 (72%)  11/24 (46%)
No  74/163 (45%) 40/81 (49%) 619/829 (75%) 56/68 (82%)  25/34 (74%)
Rather not say  3/4 (75%) 3/7 (43%) 6/7 (86%) 1/1 (100%)  2/5 (40%)
Age at arrival     
36 and more years old  41/124 (33%) 38/100 (38%) 68/114 (60%) 9/14 (64%)  4/11 (36%)
26‐35 years old  107/260 (41%) 67/127 (53%) 258/371 (70%) 27/37 (73%)  17/25 (68%)
18‐25 years old  85/149 (57%) 58/80 (73%) 276/350 (79%) 30/34 (88%)  12/22 (55%)
17 years old or less  51/55 (93%) 19/19 (100%) 101/103 (98%) 9/9 (100%)  5/5 (100%)
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Length of stay     
5 years or less  21/228 (9%) 6/85 (7%) 111/290 (38%) 11/24 (46%)  3/18 (17%)
Between 6 and 10 years  89/164 (54%) 42/91 (46%) 228/279 (82%) 29/34 (85%)  11/18 (61%)
More than 10 years 174/196 (89%) 134/150 (89%) 364/369 (99%) 35/36 (97%)  24/27 (89%)
Year of HIV diagnosis     
2008‐2009  36/85 (42%) 25/54 (46%) 69/103 (67%) 12/15 (80%)  4/11 (36%)
2010‐2012  150/329 (46%) 89/164 (54%) 323/452 (71%) 34/46 (74%)  21/32 (66%)
2013‐2015  98/174 (56%) 68/108 (63%) 311/383 (81%) 29/33 (88%)  13/20 (65%)
HET: Heterosexuals; MSM: Men who have sex with men; PWID: People who inject drugs 
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Table 4. Factors associated with HIV post‐migration acquisition by mode of transmission and 
sex: results from mixed‐effects logistic regression analyses [adjusted OR (95% Confidence 
Intervals ‐ CI)]. Results, including CIs and p‐values, based on multiple imputations (n=50) of 
unknown HIV infection times 
  Heterosexual 
women 
Heterosexual 
men 
MSM
  N=588 N=326 N=938
  aOR (95% CI) aOR (95% CI) aOR (95% CI)
Area of origin  p*=0.611  p*=0.390  p*=0.728 
European migrants  Referent Referent Referent
Sub‐Saharan African  1.0 (0.5‐2.2) 0.4 (0.1‐1.4) 0.6 (0.2‐1.6)
Latin America & Caribbean  1.7 (0.6‐4.3) 0.7 (0.2‐2.8) 1.0 (0.6‐1.8)
Other  1.0 (0.2‐4.7) 0.5 (0.1‐2.4) 0.9 (0.4‐1.9)
Length of stay  p*<0.001  p*<0.001  p*<0.001 
5 years or less  Referent Referent Referent
Between 6 and 10 years  7.5 (3.7‐15.4) 6.4 (2.2‐18.1) 7.4 (4.2‐13.2)
More than 10 years  34.7 (15.7‐76.8) 47.0 (14.0‐157.6) 54.3 (21.6‐136.6)
Age at arrival  p*=0.117    p*=0.121 
36 and more years old  Referent Referent
26‐35 years old  1.3 (0.6‐2.6) 1.5 (0.8‐2.9)
18‐25 years old  1.6 (0.7‐3.5) 2.1 (1.0‐4.4)
17 years old or less  4.9 (1.2‐20.2) 4.0 (0.7‐21.8)
Year of HIV diagnosis  p*=0.032  p*=0.046  p*<0.001 
2008‐2009  Referent Referent Referent
2010‐2012  1.8 (0.8‐4.0) 2.3 (0.8‐6.4) 2.3 (1.1‐4.7)
2013‐2015  3.4 (1.3‐9.1) 4.2 (1.4‐12.9) 6.9 (3.0‐15.7)
Legal status      p*=0.056 
EU nationals/with residence permit 1
In visa/asylum/refugee status  0.4 (0.2‐1.1)
Uncertain status and unknown  0.4 (0.2‐1.1)
                 *p‐values from global Wald tests 
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